Decentralizing Clinical Trials: What have we learned, what do we want to keep, what do we want to change?
As sites, CRO’s and sponsors adapted at speed to find methods to ensure patient safety and continuity of clinical research during the medical emergency, we now must take time to reflect. Decentralizing clinical trials must meet the needs of patients, sites and sponsors. To be successful, the industry and sites must work together to harness experience and expertise, defining best practice and increasing optionality and inclusivity of clinical research as a choice for all.
Join the Syneos Health Decentralized Solutions team to learn how to adopt DCT technologies and methodologies that work for sites, patients and sponsors.
Breakout Sessions:
Innovative Methods to Revolutionize Your Business Development Practices
If your business development (BD) efforts involve calling the same people for study leads you were using five years ago, your site is likely missing out on valuable opportunities. Join this discussion to find out how other sites have reinvigorated their business development processes and found new channels for growth.
Facilitators
- Adrienne Bush, MA, Director, SSU and Regulatory, Site Identification, Syneos Health
- Andrew Kimball, VP, Business Development, Meridian Clinical Research
- Brad Pryde, Co-Founder, OneThree Biotech
FDA Audits: Yes, That Really Happened!
FDA audits are an inevitable reality that all sites should be prepared for before they are audited. Hear perspectives from those who have experienced FDA inspections to learn how they prepared for the audit and what measures they have implemented to ensure future inspection-readiness. You will have the opportunity to share your audit experiences and hear from others to help you prepare for, lead, and follow up on an FDA audit.
Facilitator
- Lisa Kodis, MSN, RN, Associate Director of Research Nursing, Project Delivery, Illingworth Research Group, Syneos Health
Panelists
- Shivani Shah, MS, ACRP-CP, Exec. Director of Clinical Operations, DM Clinical Research
- David Vulcano, MBA, MSW, VP, Research Compliance & Integrity, HCA Healthcare
- Ana Marquez, MSF, President, Clinical Research Partners
Protocol Feasibility: Tactics & Tools for Success
Assessing the feasibility of a protocol for your site is an important task. Failure to assess the right sections of a protocol could cost your site financially and impact future study acceptance. Sites now have report cards, so it is important to set your site up to receive an A+ grade! Join this session to learn how to utilize your historical data and communicate constructively for successful study acquisition.
Facilitator
- Marie Emms, VP Site & Patient Access, Syneos Health
Panelists
- Jennifer Doraski, US Site Partnership Manager, Oncology, Sanofi
- Edward Czerwinski, MD, PhD, Senior Medical Director, Futuremeds
- Steven Geller, MD, FACP, CPI, Medical Director, Centennial Medical Group
Level Up Your Recruitment Methods
Our work starts and ends with the patient. As a result, nothing is more important than the adoption of innovative recruitment methods. In this session, attendees will share their most successful recruitment tactics, including advertising and social media campaigns, that empowered them to meet milestones and coordinate site- and sponsor-directed efforts to ensure we are delivering highly effective treatments that best support and reach patients faster.
Facilitator
- Marie Emms, VP Site & Patient Monitoring, Syneos Health
Panelists
- Jason Roth, VP, Business Development, Platinum Research Network
- Joss Warren, Head of Strategy and Partnerships, THREAD Research
- Miaesha Campbell, Director, Patient Recruitment & Retention, Medpace
PLENARY SESSIONS:
The Importance of Successful Site Relationships
Speaker:
- Marie Emms
SPRIA & Site Tank
Speaker:
- Scott Scarola